" class="no-js "lang="en-US"> Biotechnology Archives - Medtech Alert
Saturday, February 04, 2023

Sort by:


Top Post

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer

enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced […]

ADARx Pharmaceuticals Raises $46 Million in Financing as Lead Product Enters the Clinic

ADARx Pharmaceuticals, a clinical-stage biotechnology company developing RNA-targeting therapeutics, has announced the close of a […]

Vector BioPharma and iBET Collaborate to Develop High-throughput Analytical Methods and Scalable Processes for Gene Delivery

Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and […]

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement

Biocytogen Pharmaceuticals (Beijing), a clinical-stage biotechnology company with a focus on the antibody discovery and […]

Phio Pharmaceuticals Announces New Clinical Program to Study PH-762 for the Treatment of Cutaneous Squamous Cell Carcinoma

Phio Pharmaceuticals has announced it expects to file an IND in the US in the […]

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more